FDA Inspection 1187410 - Boehringer Ingelheim Fremont, Inc. - November 04, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer Ingelheim Fremont, Inc.

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Fremont, Inc., with an inspection on November 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Fremont, Inc.
Inspection Date: November 4, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 817f2419-ae3e-4fdf-b387-b7551f09fb7e

Violation Codes1

21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.